TriangleFOR PATIENTS · SOURCE READING
Donor lymphocyte infusion (DLI)
Source: Chronic Myeloid Leukemia Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: April 9, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Donor lymphocyte infusion (DLI) is a cancer treatment that may be used after stem cell transplant. Lymphocytes (a type of white blood cell) from the stem cell transplant donor are removed from the donor's blood and may be frozen for storage. The donor's lymphocytes are thawed if they were frozen and then given to the patient through one or more infusions. The lymphocytes see the patient's cancer cells as not belonging to the body and attack them.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice